The PPARγ K422Q mutation does not contribute to troglitazone inefficiency in colon cancer treatment
To access this article, please choose from the options below
PII: S0304-3835(04)00779-7
doi:10.1016/j.canlet.2004.10.011
© 2004 Elsevier Ireland Ltd. All rights reserved.
